SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

BREAKING BOUNDARIES OF SCIENCE, TECHNOLOGY, MEDICINE, ART & HEALTHCARE POLICY

Session Chairs: Dr. Jethro L. Hu, MD and Dr. Lisa Rogers, DO

3:30 – 3:45 PM
Novel Radiopharmaceuticals for Molecular Imaging of Brain Tumor Metabolism

Corinne Beinat, PhD
Department of Radiology, Stanford University, USA

3:45 – 4:00 PM
Extrachromosomal DNA – Cancer’s Dynamic Circular Genome, and its Impact on Brain Cancer

Paul Mischel, MD
Professor and Vice Chair of Research for the Department of Pathology and Institute Scholar of ChEM-H, Stanford University

4:00 – 4:15 PM
Identification of Excellent Prognosis IDH Wild Type Glioblastomas Using Genomic and Metabolomic Profiling

Donna Edwards, MD, PhD
Radiation Oncology, University of Michigan

4:15 – 4:30 PM
Switch in Energy Phenotype and Response to Ketone Bodies in Recurrent Glioblastoma Cancer Stem Cells

Lisa Rogers, DO

Medical Director, Brain Metastasis Program Hermelin Brain Tumor Center Department of Neurosurgery Henry Ford Health

4:30 – 4:45 PM
DIET2TREAT – A Phase 2 Randomized Study of a Ketogenic Diet Vs Standard Diet for Patients With Newly Diagnosed Glioblastoma Receiving Standard-of-Care Chemoradiation

Jethro Hu, MD
Neuro-oncology, Cedars-Sinai Medical Center

4:45 – 5:00 PM
Q & A

Session Chairs

March 14 @ 15:30
15:30 — 17:00 (1h 30′)

Room 407

Neurooncology and Stem cell

Add